[
    [
        {
            "time": "2020-11-14",
            "original_text": "美国超低温存储冷柜已经脱销，海尔生物等探讨潜在的疫苗低温存储解决方案",
            "features": {
                "keywords": [
                    "超低温存储",
                    "冷柜",
                    "脱销",
                    "海尔生物",
                    "疫苗"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗设备",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "美国超低温存储冷柜已经脱销，海尔生物等探讨潜在的疫苗低温存储解决方案",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-11-14",
            "original_text": "复星医药(02196.HK)分拆GrandPharma最终定价每股1500卢比",
            "features": {
                "keywords": [
                    "复星医药",
                    "分拆",
                    "GrandPharma",
                    "定价",
                    "1500卢比"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(02196.HK)分拆GrandPharma最终定价每股1500卢比",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-11-14",
            "original_text": "新冠疫苗临床获批、创新药物上市……刚离开四叶草，法国德国企业就迎来利好",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "临床获批",
                    "创新药物",
                    "法国",
                    "德国"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "新冠疫苗临床获批、创新药物上市……刚离开四叶草，法国德国企业就迎来利好",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-11-14",
            "original_text": "复星医药(02196)和BioNTech(BNTX.US)宣布其新冠候选疫苗BNT162b2在中国获批临床",
            "features": {
                "keywords": [
                    "复星医药",
                    "BioNTech",
                    "新冠疫苗",
                    "BNT162b2",
                    "临床试验"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(02196)和BioNTech(BNTX.US)宣布其新冠候选疫苗BNT162b2在中国获批临床",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-11-14",
            "original_text": "一周药闻丨复星新冠疫苗临床试验获批 辉瑞JAK抑制剂达到3期临床终点",
            "features": {
                "keywords": [
                    "复星",
                    "新冠疫苗",
                    "临床试验",
                    "辉瑞",
                    "JAK抑制剂",
                    "3期临床"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "一周药闻丨复星新冠疫苗临床试验获批 辉瑞JAK抑制剂达到3期临床终点",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-11-14",
            "original_text": "上市公司正负面新闻2020年11月14日星期六",
            "features": {
                "keywords": [
                    "上市公司",
                    "正负面新闻"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "上市公司正负面新闻2020年11月14日星期六",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 5,
                "Source_Recency": 3
            }
        }
    ]
]